BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 579916)

  • 1. [Cellular immunity and its prognostic value in patients with breast cancer (proceedings)].
    Kitschke HJ; Buddemeier D; Krebs D
    Arch Gynakol; 1977 Jul; 224(1-4):475-6. PubMed ID: 579916
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local cellular and tributary lymphocyte immunity in cancer of the breast. Diagnostic and prognostic evaluations].
    Boscaino N; De Falco A
    Arch Sci Med (Torino); 1978; 135(2):209-18. PubMed ID: 210742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of immunologic variables in breast carcinoma.
    Baral E; Blomgren H; Petrini B; Wasserman J; Ogenstad S; Silfverswärd C
    Acta Radiol Ther Phys Biol; 1977 Oct; 16(5):417-26. PubMed ID: 602812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of some parameters of cellular immunity in breast cancer patients.
    Seremet M; Rudolf M; Hrsak M; Kastelan M
    Acta Med Croatica; 1992; 46(1):9-13. PubMed ID: 1380363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Remote lymph nodes in the immunodiagnosis of cancer of the breast (prognostic value)].
    Sarría JA; Cismondi B; Irigoyen ML; Spitale L
    Rev Fac Cien Med Univ Nac Cordoba; 1982; 40(3-4):3-18. PubMed ID: 6927027
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of cellular immunity to autologous breast carcinoma and glycoprotein 55.
    Black MM; Zachrau RE; Ashikari RH; Hankey BF
    Arch Surg; 1989 Feb; 124(2):202-6. PubMed ID: 2644921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problem of immunity to breast cancers.
    Zimmermann A; Ruchti C; Roos B; Cottier H
    Prog Clin Biol Res; 1977; 12():75-89. PubMed ID: 335407
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular responses to autologous breast cancer tissue. Sequential observations.
    Black MM; Leis HP
    Cancer; 1973 Aug; 32(2):384-9. PubMed ID: 4579092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin window reactivity to autologous breast cancer. An index of prognostically significant cell-mediated immunity.
    Black MM; Zachrau RE; Hankey BF; Wesley M
    Cancer; 1988 Jul; 62(1):72-83. PubMed ID: 3383122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of oral BCG treatment on the immune system of cancer patients (proceedings)].
    Melchert F; Goldhofer W; Kreienberg R; Lemmel EM
    Arch Gynakol; 1977 Jul; 224(1-4):476-7. PubMed ID: 579917
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immunity & prognosis of human mammary carcinoma.
    Abrol SK; Shinghal RN; Saha K
    Indian J Med Res; 1984 Feb; 79():199-206. PubMed ID: 6611308
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of cellular immunity in peripheral blood and bone marrow in breast cancer patients].
    Kitschek HJ; Neth R; Tietje K; Krebs D
    Arch Gynecol; 1979 Jul; 228(1-4):606-7. PubMed ID: 485503
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Recent studies with the methanol extraction residue fraction of tubercle bacilli (MER): efficacy of distal administration against solid tumors of experimental animals, and stimulation of cellular immunologic responsiveness in cancer patients.
    Weiss DW; Cohen D; Yron I; Stupp Y; Izak G
    Isr J Med Sci; 1975 Dec; 11(12):1397. PubMed ID: 1218995
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of thymus-dependent lymphocytes in the biology of human breast cancer.
    Barr RD; McCulloch PB
    Can J Surg; 1979 Nov; 22(6):503-4. PubMed ID: 315259
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunity of regional lymph nodes in breast cancer patients].
    Dreesen D; Kitschke HJ; Krebs D; Stegner HE; Arning F; Böcker W
    Arch Gynecol; 1979 Jul; 228(1-4):607-8. PubMed ID: 485504
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Relationship between the DNCB test and prognosis in cancer patients.
    Dubois JB; Serrou B
    Br J Surg; 1974 Apr; 61(4):326. PubMed ID: 4832661
    [No Abstract]   [Full Text] [Related]  

  • 20. The delayed hypersensitivity reaction in cancer patient: observations on sensitization by DNCB.
    Chakravorty RC; Curutchet HP; Coppolla FS; Park CM; Blaylock WK; Lawrence W
    Surgery; 1973 May; 73(5):730-5. PubMed ID: 4697093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.